Bevacizumab suppresses choroidal neovascularization secondary to pathologic myopia: A pilot study

被引：0
|
作者：
Nguyen, QD
Shah, SM
Tatlipinar, S
Do, DV
Van Anden, E
Campochiaro, PA
机构：
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2005年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1379
引用
收藏
页数：1
相关论文
共 50 条
  • [1] INTRAVITREAL BEVACIZUMAB FOR EXTRAFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA
    Parodi, Maurizio B.
    Iacono, Pierluigi
    Papayannis, Alessandro
    Kontadakis, Stylianos
    Cascavilla, Maria L.
    Zucchiatti, Ilaria
    Bandello, Francesco
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (03): : 593 - 597
  • [2] Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab
    Laud, Ketan
    Spaide, Richard F.
    Freund, K. Bailey
    Slakter, Jason
    Klancnik, James M., Jr.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (08): : 960 - 963
  • [3] Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia
    Tewari, Asheesh
    Dhalla, Mandeep S.
    Apte, Rajendra S.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (09): : 1093 - 1094
  • [4] Conbercept for treatment of choroidal neovascularization secondary to pathologic myopia
    Yan, Ming
    Huang, Zhen
    Lian, Hai-Yan
    Song, Yan-Ping
    Chen, Xiao
    ACTA OPHTHALMOLOGICA, 2019, 97 (05) : E813 - E814
  • [5] Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years?
    Bogomil Voykov
    Faik Gelisken
    Werner Inhoffen
    Michael Voelker
    Karl Ulrich Bartz-Schmidt
    Focke Ziemssen
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 543 - 550
  • [6] Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years?
    Voykov, Bogomil
    Gelisken, Faik
    Inhoffen, Werner
    Voelker, Michael
    Bartz-Schmidt, Karl Ulrich
    Ziemssen, Focke
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (04) : 543 - 550
  • [7] Choroidal Neovascularization in Pathologic Myopia
    Dave, Vivek
    Narayanan, Raja
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 150 (05) : 752 - 752
  • [8] PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION
    HOTCHKISS, ML
    FINE, SL
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1981, 91 (02) : 177 - 183
  • [9] DIFFERENT DOSING OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION BECAUSE OF PATHOLOGIC MYOPIA
    Wakabayashi, Taku
    Ikuno, Yasushi
    Gomi, Fumi
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (05): : 880 - 886
  • [10] Intravitreal aflibercept for the treatment of choroidal neovascularization associated with pathologic myopia: a pilot study
    Korol, Andrii R.
    Zadorozhnyy, Oleg S.
    Naumenko, Volodymyr O.
    Kustryn, Taras B.
    Pasyechnikova, Nataliya V.
    CLINICAL OPHTHALMOLOGY, 2016, 10 : 2223 - 2229
12345